Optimal timing of surgery after chemoradiation for advanced rectal cancer: preliminary results of a multicenter, nonrandomized phase II prospective trial
about
Effect of Interval between Neoadjuvant Chemoradiotherapy and Surgery on Oncological Outcome for Rectal Cancer: A Systematic Review and Meta-AnalysisNeoadjuvant chemoradiation therapy and pathological complete response in rectal cancerRisk factors for local recurrence following neoadjuvant chemoradiotherapy for rectal cancersRectal cancer: An evidence-based update for primary care providersCurrent debate in the oncologic management of rectal cancer.Gene polymorphisms predict toxicity to neoadjuvant therapy in patients with rectal cancerOrgan Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and'Liver-first' approach for metastatic colorectal cancer.Chromosomal copy number alterations are associated with persistent lymph node metastasis after chemoradiation in locally advanced rectal cancerPredictive Response Value of Pre- and Postchemoradiotherapy Variables in Rectal Cancer: An Analysis of Histological DataEvaluation of capecitabine and oxaliplatin administered prior to and then concomitant to radiotherapy in high risk locally advanced rectal cancer.Neoadjuvant therapy before surgical treatmentAvoiding radical surgery after pre-operative chemoradiotherapy: a possible therapeutic option in rectal cancer?Systematic review and meta-analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancer.The emerging role of neoadjuvant chemotherapy for rectal cancerCould preoperative short-course radiotherapy be the treatment of choice for localized advanced rectal carcinoma?Molecular diagnosis of response to neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer.Predicting complete response: is there a role for non-operative management of rectal cancer?Chromosomal copy number alterations are associated with tumor response to chemoradiation in locally advanced rectal cancerIdentification of a biomarker profile associated with resistance to neoadjuvant chemoradiation therapy in rectal cancerReview of Neoadjuvant Chemotherapy Alone in Locally Advanced Rectal Cancer.Can an IL13 -1112 C/T (rs1800925) polymorphism predict responsiveness to neoadjuvant chemoradiotherapy and survival of Chinese Han patients with locally advanced rectal cancer?Advances and challenges in treatment of locally advanced rectal cancer.Treatment of locally advanced rectal cancer: controversies and questions.Distribution of residual cancer cells in the bowel wall after neoadjuvant chemoradiation in patients with rectal cancer.Surgical issues in locally advanced rectal cancer treated by preoperative chemoradiotherapy.Mortality risk after preoperative versus postoperative chemotherapy and radiotherapy in lymph node-positive rectal cancer.Integrated genomic profiling identifies microRNA-92a regulation of IQGAP2 in locally advanced rectal cancerAn 80-gene set to predict response to preoperative chemoradiotherapy for rectal cancer by principle component analysisDoes Delaying Surgical Resection After Neoadjuvant Chemoradiation Impact Clinical Outcomes in Locally Advanced Rectal Adenocarcinoma?: A Single-Institution Experience.Optimal timing of surgery after neoadjuvant chemoradiation therapy in locally advanced rectal cancer.Future directions in combined modality therapy for rectal cancer: reevaluating the role of total mesorectal excision after chemoradiotherapyAn observational study of extending FOLFOX chemotherapy, lengthening the interval between radiotherapy and surgery, and enhancing pathological complete response rates in rectal cancer patients following preoperative chemoradiotherapy.Treatment Interval between Neoadjuvant Chemoradiotherapy and Surgery in Rectal Cancer Patients: A Population-Based Study.Delaying surgery after neoadjuvant chemoradiotherapy improves prognosis of rectal cancer.Pathological Assessment of Rectal Cancer after Neoadjuvant Chemoradiotherapy: Distribution of Residual Cancer Cells and Accuracy of Biopsy.Clinical predictive factors of pathologic complete response in locally advanced rectal cancer.Results of intraoperative electron beam radiotherapy containing multimodality treatment for locally unresectable T4 rectal cancer: a pooled analysis of the Mayo Clinic Rochester and Catharina Hospital EindhovenCurrent issues in locally advanced colorectal cancer treated by preoperative chemoradiotherapyCritical appraisal of the 'wait and see' approach in rectal cancer for clinical complete responders after chemoradiation.
P2860
Q26748798-94F2C126-95CD-472F-B075-36D589E6614EQ26796352-B4A564C6-E746-4902-A7C6-8BF226E0C941Q26853016-6568E363-F1F6-4264-8E0C-431578E2F073Q27013068-B4092176-AC2C-4168-8D76-0FA3733F3EBAQ28072948-29041D3D-664B-440F-AEB6-CA6E1B902008Q28392548-ACD539F9-45EF-4F08-8768-DE0FC28E6224Q30370343-8EB9730B-D19D-4BF8-BA1C-497C5A735F2AQ30373308-52A106D0-A286-40D3-8249-F28C9E730185Q30514122-37BFA429-6CCC-4281-B373-7F0C7C7E05D4Q31046735-88A151B6-D267-44AD-B6CD-A8F5209DF6B3Q33411783-E545C337-8724-4B3B-A0E2-C06357F51FADQ33697924-CCC02113-9785-4DCD-A488-33073E6E9177Q34093710-E1B833D5-7E95-480D-B35E-3E76F07D4BC1Q34169310-5E1C7878-1776-477D-8191-37E5DD753C82Q34234935-5F557BC7-BF2A-4265-8A61-148813B8B352Q34719568-61ADFEB7-7CFC-4DD1-BDB9-CA40CCA79CEFQ35013576-C769ABD6-C123-418E-9B15-3AD01E0C9CBEQ35029046-5605E427-9247-49F6-9BFF-CC342A46DA2CQ35100017-8C38FA4A-9B42-489C-A0A8-AB34071768F1Q35460703-83C8108A-D1E4-4AC7-82AC-CA3A3AC4350DQ35680327-1F37529F-75B3-4AC8-9B43-05E9060EF001Q36014263-EAC82D55-048F-4B5D-B649-69CBD51AF155Q36025983-6D7BD92C-CDFB-4452-BD00-763EFD033ECBQ36351882-0CD6D51A-0A70-4BB7-823E-ED24A41B1CB3Q36358764-AD8644B1-1A5C-44F4-BA3D-33EE6A97ECE5Q36514882-39A1665E-1D86-49F8-94FE-D9BEF8BCFCE2Q36551503-7ABBDE1B-0464-4064-92F1-A9E7869150E1Q36584991-60736C1B-30F2-4618-9327-DC7A772A6349Q36824711-35433CAC-D012-4D0E-B692-C3C8028B9122Q36880544-65EF424F-1DCB-4D90-AF77-184FC3C4D9B5Q36897686-4622DF0B-C45D-4F57-BDD7-FB7D35687394Q37106318-AC543E7A-37AA-4E42-AAC3-02043E0874F1Q37173767-0991DB96-4815-4B84-9F54-8C36B7DF6F94Q37227461-77EBD8CA-65C3-40DB-8659-1C45DC2690BAQ37263114-5757588A-0875-4365-BD5D-B2F9C9E38974Q37323833-43BC0E7F-4E2E-4418-80FD-04D3427BCFADQ37362938-4758A681-1068-4128-B1BF-86E3EAB92392Q37525377-E86A2C6D-8CE4-4034-83C2-B3570973600CQ37602735-33AB9854-8E79-4F87-A0C9-AD4BC089A7EDQ38005955-D787F6EB-0D97-4B7F-8A27-8FC6532DE7A2
P2860
Optimal timing of surgery after chemoradiation for advanced rectal cancer: preliminary results of a multicenter, nonrandomized phase II prospective trial
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Optimal timing of surgery afte ...... zed phase II prospective trial
@en
type
label
Optimal timing of surgery afte ...... zed phase II prospective trial
@en
prefLabel
Optimal timing of surgery afte ...... zed phase II prospective trial
@en
P2093
P2860
P921
P1433
P1476
Optimal timing of surgery afte ...... zed phase II prospective trial
@en
P2093
Emily K Bergsland
Julio Garcia-Aguilar
Karin Avila
Peiguo Chu
Richard M Krieg
Timing of Rectal Cancer Response to Chemoradiation Consortium
P2860
P304
P356
10.1097/SLA.0B013E3182196E1F
P407
P577
2011-07-01T00:00:00Z